as on December 5, 2025 at 9:43 pm IST
Day's Low
Day's High
0.49%
Downside
4.71%
Upside
52 Week's Low
52 Week's High
81.94%
Downside
2.77%
Upside
Check Oruka Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-2.0908
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Oruka Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $1.4B | NA | NA | 0.00% | |
| BUY | $43.7B | 410.81% | -16.34 | -264.83% | |
| BUY | $62.5B | 258.57% | 1690.32 | 1.36% | |
| BUY | $118.7B | 100.27% | 30.49 | 31.35% | |
| BUY | $76.7B | 46.78% | 17.33 | 32.13% |
The Oruka Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Oruka Therapeutics Inc investment value today
Current value as on today
₹1,55,457
Returns
₹55,457
(+55.46%)
Returns from Oruka Therapeutics Inc Stock
₹49,312 (+49.31%)
Dollar Returns*
₹6,146 (+6.15%)
Search interest for Oruka Therapeutics Inc Stock has increased by 156% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:156% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, ORKA stock has moved up by 89.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 172.2% return, outperforming this stock by 120.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 930.9% return, outperforming this stock by 909.9%
| Organisation | Oruka Therapeutics Inc |
| Headquarters | 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025 |
| CEO | Dr. Lawrence Otto Klein Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Joana Goncalves M.D. | Chief Medical Officer |
Ms. Laura Sandler | Chief Operating Officer |
Mr. Alan Lada | Vice President of Investor Relations |
Mr. Christopher Finch | Vice President of Corporate Development & Strategy |
Dr. Joe Senn Ph.D. | Senior Vice President of Nonclinical Research & Development |
Dr. Lawrence Otto Klein Ph.D. | President, CEO & Director |
Mr. Paul T. Quinlan | General Counsel & Secretary |
Mr. Arjun Agarwal CPA | Senior VP of Finance & Treasurer |
Dr. Rajiv Panwar | VP and Head of Chemistry, Manufacturing & Controls |
Oruka Therapeutics Inc share price today is $30.37 as on . Oruka Therapeutics Inc share today touched a day high of $31.8 and a low of $30.22.
Oruka Therapeutics Inc share touched a 52 week high of $31.21 on and a 52 week low of $5.49 on . Oruka Therapeutics Inc stock price today i.e. is trending at $30.37,which is 2.69% down from its 52 week high and 453.69% up from its 52 week low.
Oruka Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Oruka Therapeutics Inc (ORKA) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Oruka Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Oruka Therapeutics Inc share’s latest price of $30.37 as on December 5, 2025 at 9:43 pm IST, you will get 0.3293 shares of Oruka Therapeutics Inc. Learn more about
fractional shares .